You searched for Kerry Taylor-Smith

Travel risk
12 April, 2021
It’s not just shifting portfolios and expanding markets that supply chain strategies need to take into account. Our understanding of what constitutes an effective cold chain is continually developing, and it is risk management that makes implementing any of it possible. Kerry Taylor-Smith finds out how best to set the cold chain up for success from Brandon Staten of Janssen’s device and packaging centre of excellence and George Baryannis, senior lecturer in AI at the University of Huddersfield.

The race to digitize
29 December, 2020
At the beginning of 2020, both AstraZeneca and Novartis – widely acknowledged as industry leaders in applying digital technologies to their trial processes – went public with updates about their so-called ‘transformations’. So, how much have all the apps and Nasa-inspired mission control dashboards really done for clinical operations and supply? Kerry Taylor-Smith assesses the industry’s advances, speaking to Luca Russo, the global head of the clinical supply chain for Janssen Research & Development, and Lisheng Gao, analyst at Lux Research, to find out more.

Ghost writer
01 September, 2020
Medical writers have tried just about every technique to speed up the process of producing clinical study reports, but strict schedules and inspirational project management can only get you so far. The development of contextual AI could allow sponsors to automate the most laborious aspects of drafting regulatory submissions and free their expert communicators to do what they do best. Kerry Taylor-Smith speaks to the Pistoia Alliance’s Dr Nick Lynch about how robot writers can help get products to market faster.

The cold war
31 January, 2020
Cold-chain shipping involves navigating a number of challenges to prevent product wastage. Eva-Lotta Persson, MSc/CSCP clinical supply chain lead, AstraZeneca R&D Mölndal, speaks to Kerry Taylor-Smith about how to overcome these issues to ensure an efficient, effective cold chain.

The domino effect
04 July, 2019
The importance of having a streamlined approach to the cold chain cannot be overstated. However, with its inherent complexities, this can be highly challenging to achieve and maintain. An automated receipt process for temperature-controlled shipments is a key strategy to attain better total end-to-end control. Henk Dieteren, senior clinical supply manager at Grünenthal, speaks to Kerry Taylor-Smith about the challenges and opportunities of this technology.

A sea change
14 December, 2018
The last 25 years have seen a dramatic evolution in clinical trials and processes. The delivery of investigational medicinal products to clinical sites and patients is continually shifting, yet the need to supply patients and sponsors with safe, flexible packaging remains. Kerry Taylor-Smith speaks to Dr Wynand Smythe about the challenges involved and how to maximise efficiencies.

The indefinite particle
23 March, 2018
Jonas Hoeg Thygesen, research scientist at the Microanalysis Centre, Novo Nordisk, speaks to Kerry Taylor-Smith about methods and techniques for particle analysis and characterisation. He discusses the strengths and weaknesses of current analytical methods for particle identification and characterisation, and examines future methods.

Ensuring drug safety during clinical trials
12 January, 2018
Risk-based monitoring can promote more efficient data standardisation and speed up clinical trial timelines. Kerry Taylor-Smith speaks to Hanne Cloetta Lang, vice-president at Novo Nordisk Clinical Operations, about how technology can identify critical values in studies to minimise the number of sites monitored and reduce costs.

Safety fast: ensuring drug safety during clinical trials
15 December, 2017
Risk-based monitoring can promote more efficient data standardisation and speed up clinical trial timelines. Kerry Taylor-Smith speaks to Hanne Cloetta Lang, vice-president at Novo Nordisk Clinical Operations, about how technology can identify critical values in studies to minimise the number of sites monitored and reduce costs.

Unique device identifiers for medical equipment
03 November, 2017
Soon, every piece of medical equipment around the globe will be required to be marked with a unique device identifier that will enable the unambiguous verification of hardware throughout the supply chain. Kerry Taylor-Smith discusses what this will mean for the industry with Johnson & Johnson’s Mike Rose, Tom Jones, and Dennis Hahn.

Prevention of temperature deviation in the pharma packaging
03 November, 2017
Philippe François, global head of supply chain management at Novartis, discusses budget allocation and temperature-maintenance visibility for the distribution process with Kerry Taylor-Smith. He focuses on preventing temperature deviation in packaging; reducing the time that is taken on quality validation with real-time monitoring; and developing alternatives such as thermo blankets.

Cold chain challenge
10 October, 2017
Philippe François, global head of supply chain management at Novartis, discusses budget allocation and temperature-maintenance visibility for the distribution process with Kerry Taylor-Smith. He focuses on preventing temperature deviation in packaging; reducing the time that is taken on quality validation with real-time monitoring; and developing alternatives such as thermo blankets.

Name and number
10 October, 2017
Soon, every piece of medical equipment around the globe will be required to be marked with a unique device identifier that will enable the unambiguous verification of hardware throughout the supply chain. Kerry Taylor-Smith discusses what this will mean for the industry with Johnson & Johnson’s Mike Rose, Tom Jones, and Dennis Hahn.

The changing face of product identity
19 September, 2016
Internal capacity gaps need to be solved with the right outsourcing strategy. Kerry Taylor-Smith explains how document-centric organisations can switch to an information-centric setup in order to align better with new identification of medicinal products (IDMP) processes and maximise the mapping of source data systems.

The importance of being compliant – packaging and labelling processes
08 July, 2016
The developmental issues have been resolved and now the new drug that is to be used in a clinical trial needs to be packaged and labelled in a way that is economical and compliance-friendly. Kerry Taylor-Smith investigates how best to deal with packaging and labelling processes within global clinical supply chains, and why it can, at times, present problems for trials.